27 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
additional funding before the Company achieves sustainable revenues and profit from operations.
Research and development activities have required
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
funding before the Company achieves sustainable revenues and profit from operations.
Research and development activities have required significant
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
the Company achieves sustainable revenues and profit from operations.
Research and development activities have required significant capital investment since
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
activities are subject to significant risks and uncertainties, including failing to secure additional funding before the Company achieves sustainable
6-K
EX-99.1
kl1y9iwhorewwsn3
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
z6njb70oivjxf
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
2xfcs2r28n5psp
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
rz5b36pojyttbc2c2i3
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.1
8kb81jbu9 tlkf
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
ptlhqf1
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
6-K
EX-99.1
obqhf
28 May 21
Condensed Consolidated Financial Statements
4:33pm
6-K
EX-99.1
4kd0c4e3m1i5h3jty
30 Oct 20
Condensed Consolidated Financial Statements
4:30pm
6-K/A
EX-99.1
jx3x8 df4b
13 Oct 20
Condensed Consolidated Financial Statements
9:16am
6-K
EX-99.1
eystc luju3zkcjxow
14 Aug 20
Condensed Consolidated Financial Statements
4:23pm
6-K
EX-99.1
1r7nfxsbbdhvlx6k3
18 May 20
Condensed Consolidated Financial Statements
4:30pm